Report Highlights
The global market for biologics safety testing is estimated to increase from $7.4 billion in 2022 to reach $18.2 billion by 2027, at a compound annual growth rate (CAGR) of 19.9% from 2022 through 2027.
Report Includes
- 13 data tables and 16 additional tables
- An up-to-date review and analysis of the global markets for biological safety testing and related technologies
- Analyses of the global market trends, with market revenue data for 2019-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2027
- Discussion of market dynamics that impact the growth for biologics development and manufacturing testing, clinical applications, safety regulations, industry structure, and penetration of technologies within the biotech industry
- Coverage of the technological, economic, and business considerations of global biological safety testing market, with analyses and growth forecasts through 2027
- Estimation of the actual market size and revenue forecast for global biological safety testing market in USD million values, and corresponding market share analysis based on test type, application, technology, and region
- Identification of the companies best positioned to meet the increasing demand for biological safety testing owing to their proprietary technologies, product launches, mergers and acquisitions, and other strategic advantages
- Review of recent industry structure for biomarkers, R&D activities, and analysis of the competitive landscape based on recent developments and segmental revenues
- Descriptive company profiles of the market leading players, including Catalent, Eurofins Scientific, Lonza, Merck, Thermo Fisher Scientific and WuXi AppTec
Report Scope
This report aims to provide a comprehensive study of the global market for biologics safety testing, both in terms of quantitative and qualitative data, to help develop business/growth strategies, assess the market landscape, analyze their position in the current marketplace, and make informed business decisions regarding biologics safety testing products and services. Biologics safety testing includes biosafety testing & characterization of raw materials, cell bank & virus seeds, unprocessed bulks/viral harvests, and drug substance/product.
This report segments the global biologics safety testing market by application, test application, testing technology, and region of operations. BCC Research analyses each market and its applications, regulatory environments, technology, market projections, and market share. Industry growth drivers, restraints, trends, and opportunities in the biological safety testing market are also discussed in detail. The report also provides information on the competitive landscape, elaborate company profiles, and the impact of COVID-19 on the biologics safety testing market.
Report Synopsis
| Report Metrics | Details | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2021 | ||||||||||||||
| Forecast period considered | 2022-2027 | ||||||||||||||
| Base year market size | $6.2 billion | ||||||||||||||
| Market size forecast | $18.2 billion | ||||||||||||||
| Growth rate | CAGR of 19.9% for the forecast period of 2022-2027 | ||||||||||||||
| Units considered | $ Millions | ||||||||||||||
| Segments covered | application, test application, testing technology, and region | ||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, and Rest of the World | ||||||||||||||
| Countries covered | United States, Canada, France, Germany, Italy, Spain, United Kingdom, China, Japan, India, Latin America, Middle East, and Africa | ||||||||||||||
| Key Market Drivers |
|
||||||||||||||
| Companies studied |
|
Frequently Asked Questions (FAQs)
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- E-commerce Regional Analysis Market: Middle East and North Africa (IFT311A)
- Antenna: Including Patch, Embedded, Fractal, Smart and Reflectors (IFT073G)
- Semiconductor Devices for High-Temperature Applications: Market Opportunities (SMC114B)
- Grid-Scale Electricity Storage Technologies: Global Markets (EGY142C)
- Global Lithium-ion Battery Market (FCB067A)
Report Highlights
The global biological safety testing market should reach $13.1 billion by 2022 from $5.1 billion in 2017 at a compound annual growth rate (CAGR) of 20.9%, from 2017 to 2022.
Related Reports
Biosimilars: Global Markets
The global biosimilars market was valued at $23.8 billion in 2023. The market is expected to grow from $28.5 billion in 2024 to $69.2 billion by 2029, at a compound annual growth rate (CAGR) of 19.4% from 2024 through 2029.
Global Markets for Media, Sera and Reagents in Biotechnology
The global market for media, sera and reagents in biotechnology is expected to grow from $6.3 billion in 2024 and is projected to reach $9.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.1% during the forecast period of 2024 to 2029.
High-Throughput Screening: Technologies and Global Markets
The global market for high-throughput screening (HTS) is expected to grow from $23.8 billion in 2024 to $39.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.5% from 2024 through 2029.
Cell-Based Assays: Technologies and Global Markets
The global market for cell-based assays is estimated to increase from $35.3 billion in 2024 to reach $56.3 billion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Recent Reports
Current Research and Development Status of Chimeric Antigen Receptor (CAR) T-Cell Therapy Market
The global market for CAR T-cell therapy is expected to grow from $4.6 billion in 2024 and projected to reach $25.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 40.2% from 2024 to 2029.
Therapeutics for Women's Health: Technologies and Global Markets
The global therapeutics for women’s health technologies market is expected to grow from $61.5 billion in 2024 and is projected to reach $81.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.7% during the forecast period of 2024 to 2029.
2024 Protein Synthesis Research Review
Research Reviews from BCC Research provide market professionals with concise market coverage within a specific research category. These Research Reviews include portions of several market research reports that were published in 2024.
2024 DNA and RNA Synthesis Research Review
The Cell Biology industry is a multi-billion-dollar industry whose outlook is supposed to rise in the coming years. This report provides a sampling of the types of quantitative market information, analysis and guidance that has been aiding business decision making since the inception of BCC Research in 1971.
Global Markets for Media, Sera and Reagents in Biotechnology
The global market for media, sera and reagents in biotechnology is expected to grow from $6.3 billion in 2024 and is projected to reach $9.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.1% during the forecast period of 2024 to 2029.
Top Trending Reports
2024 Semiconductor Manufacturing Research Review
This 2024 Research Review of the Semiconductor Manufacturing provides a sampling of the type of quantitative market information, analysis, and guidance that BCC Research has been developing since its inception in 1971 to help its customers make informed business decisions.
Carbon Capture, Utilization & Storage Technologies
The global market for carbon capture, utilization and storage (CCUS) technologies is expected to grow from $3.4 billion in 2024 and is projected to reach $9.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 23.1% during the forecast period of 2024 to 2029.
Generative AI: Global Markets
The global market for generative AI was valued at $15.4 billion in 2023. It is projected to grow from $20.8 billion in 2024 to $94.4 billion by 2029, at a compound annual growth rate (CAGR) of 35.3% from 2024 through 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from $810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More